v3.24.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenues:    
License revenue—related party $ 2,826 $ 6,417
Operating expenses:    
Research and development 32,841 29,379
General and administrative 18,159 6,743
Total operating expenses 51,000 36,122
Loss from operations (48,174) (29,705)
Other income/(expense):    
Interest income 4,764 1,145
(Loss)/gain on currency exchange, net (85) 136
Other expense (60) (52)
Total other income 4,619 1,229
Net loss $ (43,555) $ (28,476)
Net loss per share attributable to common stockholders, basic $ (8.45) $ (32.57)
Net loss per share attributable to common stockholders, diluted $ (8.45) $ (32.57)
Weighted-average number of share of common stock outstanding, used in computing net loss per share of commonstock, basic 5,153,423 874,234
Weighted-average number of share of common stock outstanding, used in computing net loss per share of commonstock, diluted 5,153,423 874,234
Comprehensive loss:    
Net loss $ (43,555) $ (28,476)
Other comprehensive income/(loss):    
Change in unrealized gains/(losses) related to available-for-sale debt securities 208 (161)
Total other comprehensive income/(loss) 208 (161)
Total comprehensive loss $ (43,347) $ (28,637)